Cost-Effective Imaging APN Health offers Navik 3D as a significantly cheaper alternative to existing 3D cardiac mapping systems, presenting a compelling value proposition for hospitals seeking to reduce procedural costs and expand access to ablation therapies.

Market Expansion The technology is positioned for broader applications beyond cardiology, including orthopedics, neurosurgery, interventional radiology, and general interventional cardiology, signaling cross‑sell and upsell opportunities across multiple specialties.

Early Commercialization Navik 3D has achieved commercial release and clinical use, suggesting sales momentum and credibility with healthcare providers, which can be leveraged to drive pilot programs and reference customers.

Aging Population Demand Rising incidence of heart rhythm disorders among aging populations creates sustained demand for cost-effective mapping solutions, making APN Health well‑positioned to target hospitals with high volumes of ablation procedures.

Strategic Partnerships The company’s focus on leveraging existing fluoroscopic imaging and monitoring infrastructure enables partnerships with hospitals and catheter labs, facilitating rapid adoption without substantial capital upgrades.